Mersana Therapeutics, Inc. (MRSN)

Mersana Therapeutics Revenue

Mersana Therapeutics had revenue of $38.30M in the twelve months ending March 31, 2024, with 18.40% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $9.25M with 18.50% year-over-year growth. In the year 2023, Mersana Therapeutics had annual revenue of $36.86M with 38.65% growth.

• Revenue (ttm): $38.30M
• Revenue Growth: +18.40%
• P/S Ratio: 5.94
• Revenue / Employee: $311,366
• Employees: 123
• Market Cap: 227.59M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	36.86M	10.27M	38.65%
Dec 31, 2022	26.58M	26.54M	61,716.28%
Dec 31, 2021	43.00K	-785.00K	-94.81%
Dec 31, 2020	828.00K	-41.30M	-98.03%
Dec 31, 2019	42.12M	31.53M	297.61%
Dec 31, 2018	10.59M	-6.95M	-39.62%
Dec 31, 2017	17.55M	-7.63M	-30.30%
Dec 31, 2016	25.17M	14.81M	142.99%
Dec 31, 2015	10.36M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.